A carregar...
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease
OBJECTIVE: To test the safety, tolerability, and pharmacokinetics of the anti- TNF-α monoclonal antibody, infliximab, in subjects with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD). STUDY DESIGN: We conducted a multicenter, randomized, prospective trial of second IVIG infusion (2...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2856847/ https://ncbi.nlm.nih.gov/pubmed/18672254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2008.06.011 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|